de Guibert, Sophie <br/><br/>
Rituximab and DHAP followed by intensive therapy with autologous stem-cell transplantation as first-line therapy for mantle cell lymphoma.  [electronic resource] 

 -  Haematologica  Mar 2006 
 - 425-6 p.  digital 
<br/><br/> Publication Type: Comparative Study; Letter 
<br/><br/><label>ISSN: </label>1592-8721 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Murine-Derived<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Cisplatin--therapeutic use<br/>Cytarabine--therapeutic use<br/>Dexamethasone--therapeutic use<br/>Female<br/>Hematopoietic Stem Cell Transplantation<br/>Humans<br/>Lymphoma, Mantle-Cell--drug therapy<br/>Male<br/>Middle Aged<br/>Rituximab<br/>Survival Rate<br/>Transplantation, Autologous